"Hepatitis B, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
|Hepatitis B, Chronic
- Hepatitis B, Chronic
- Chronic Hepatitis B
- Hepatitis B Virus Infection, Chronic
- Chronic Hepatitis B Virus Infection
Below are MeSH descriptors whose meaning is more general than "Hepatitis B, Chronic".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B, Chronic".
This graph shows the total number of publications written about "Hepatitis B, Chronic" by people in this website by year, and whether "Hepatitis B, Chronic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis B, Chronic" by people in Profiles.
Novotny LA, Evans JG, Su L, Guo H, Meissner EG. Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies. Viruses. 2021 06 09; 13(6).
Elston DM. Hepatitis B reactivation in patients on biologics: A perfect storm. J Am Acad Dermatol. 2022 01; 86(1):37-38.
Orr C, Myers R, Li B, Jiang Z, Flaherty J, Gaggar A, Meissner EG. Longitudinal analysis of serum microRNAs as predictors of cirrhosis regression during treatment of hepatitis B virus infection. Liver Int. 2020 07; 40(7):1693-1700.
Di Bona D, Pandey JP, Aiello A, Bilancia M, Candore G, Caruso C, Colomba C, Duro G, Ligotti ME, Macchia L, Rizzo S, Accardi G. The immunoglobulin ? marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans. Immunology. 2020 02; 159(2):178-182.
Smalls DJ, Kiger RE, Norris LB, Bennett CL, Love BL. Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies. Pharmacotherapy. 2019 12; 39(12):1190-1203.
Hou W, Huo Z, Du Y, Wang C, Syn WK. Characteristics of amino acid substitutions within the "a" determinant region of hepatitis B virus in chronically infected patients with coexisting HBsAg and anti-HBs. Clin Res Hepatol Gastroenterol. 2020 11; 44(6):923-931.
Hou W, Trieu C, Du Y, Wang C, Syn WK. Profile of drug resistance mutations in nucleos(t)ide analogue-experienced chronic hepatitis B patients in Tianjin, China. Int J Antimicrob Agents. 2018 Nov; 52(5):735-736.
Rockey DC. Liver Fibrosis Reversion After Suppression of Hepatitis B Virus. Clin Liver Dis. 2016 11; 20(4):667-679.
Singal AG, Mukherjee A, Elmunzer BJ, Higgins PD, Lok AS, Zhu J, Marrero JA, Waljee AK. Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma. Am J Gastroenterol. 2013 Nov; 108(11):1723-30.
Sung JJ, Lai JY, Zeuzem S, Chow WC, Heathcote EJ, Perrillo RP, Brosgart CL, Woessner MA, Scott SA, Gray DF, Gardner SD. Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B. J Hepatol. 2008 May; 48(5):728-35.